Clinical utility of real 3D angiography, a newly developed technology grown out of rotational DSA, in transcather arterial embolization (TAE) for treatment of liver cancer

2001 ◽  
Vol 120 (5) ◽  
pp. A558-A559
Author(s):  
M YASUDA ◽  
Y NITOH ◽  
N YAOSHIDA ◽  
T YOSHIKAWA
Keyword(s):  
Liver Cancer ◽  
Clinical Utility ◽  
Arterial Embolization ◽  
3D Angiography

Incidence And Risk Factors Of Contrast Nephropathy After Tace In Patients With Liver Cancer And Chronic Kidney Disease

2021 ◽  
Vol 44 (3) ◽  
pp. E19-24
Author(s):  
Kun-Kun Cao ◽  
Ning Ding ◽  
Xiao-We Li ◽  
Jia-Ming Zhong ◽  
Jian Zhai ◽  
...  
Keyword(s):  
Risk Factors ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Liver Cancer ◽  
Serum Albumin ◽  
Multivariate Logistic Regression Analysis ◽  
Arterial Embolization ◽  
Solitary Kidney ◽  
Kidney Volume ◽  
Iodized Oil

Purpose: Incidence of contrast induced nephropathy (CIN) and related risk factors in patients with liver cancer and chronic kidney disease after trans-catheter arterial chemoembolization (TACE) is higher. The purpose of this study was to investigate the feasibility and safety of TACE therapy in such patients. Methods: A retrospective analysis was performed on 103 patients with liver cancer and chronic kidney disease who underwent TACE treatments. TACE was performed according to Seldinger’s technique of arterial embolization with minor modifications. Based on CIN diagnostic criteria, patients were divided into non-CIN (n=89) and CIN (n=14) groups. Multiple clinical parameters were assessed for the two groups after TACE. Serum creatinine levels were measured 48-72 h after TACE. Results: Tumor size (>5 cm), TACE frequency, contrast agent dosage, solitary kidney, volume of iodized oil used in the TACE (ml) and urea levels were significantly higher in CIN group in comparison with the non-CIN group, while serum albumin and haemoglobin levels were significantly lower. Multivariate logistic regression analysis confirmed that the volume of iodized oil and TACE frequency were significantly positively correlated, and serum albumin level was negatively correlated in the CIN group. Conclusion: Volume of iodized oil, TACE frequency and low serum albumin levels were found to be independent risk factors for CIN after TACE. Thus, it is safe and feasible for hepatocellular carcinoma patients with chronic kidney disease to receive TACE treatment, but adverse events management after TACE needs to be addressed.

Clinical utility and limitations of tumor-feeder detection software for liver cancer embolization

2013 ◽  
Vol 82 (10) ◽  
pp. 1665-1671 ◽  
Author(s):  
Jin Iwazawa ◽  
Shoichi Ohue ◽  
Naoko Hashimoto ◽  
Osamu Muramoto ◽  
Takashi Mitani
Keyword(s):  
Liver Cancer ◽  
Clinical Utility ◽  
Detection Software
Sign in / Sign up

Export Citation Format

Share Document